Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.
about
Use of Direct-Acting Oral Anticoagulants in Nonagenarians: A Call for More Data.Successful Revascularization of Acute Middle Cerebral Artery Occlusion by Intravenous Thrombolysis While on Apixaban.Healthcare utilization and costs for patients initiating Dabigatran or Warfarin.The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ.Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed.Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.Pipe Dreams About Apixaban for Stroke Prevention in Renal Impairment.The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation.A Case of a Reversible Neurologic Adverse Reaction to Apixaban Confirmed by Re-Challenge.Left Atrial Appendage Thrombus Formation in a Patient on Dabigatran Therapy Associated With ABCB1 and CES-1 Genetic Defect.Interindividual variability in dabigatran and rivaroxaban exposure: contribution ofABCB1genetic polymorphisms and interaction with clarithromycin
P2860
Q31066944-16FE07B3-7B3C-460B-98BB-E03CD5837129Q33795510-DD9D27A6-7D82-4F0E-98C6-B7FB8AD663DEQ33823354-7F83C1C9-BD5E-4825-8204-4433128DD273Q36396649-C260F110-73F7-4FAC-8EBA-97E04A333006Q38647787-6B830222-EC9F-422A-9867-7FB71C6B10FAQ42092734-9979B64A-7DCF-445B-BE52-DB1715E0BFD0Q43845344-9CFD7CB1-30DA-41EA-84AC-59896B483791Q45974877-7A30ACA6-A7BE-43A4-8905-20AED6F22484Q53724995-86D5ADEA-F490-455D-A4B4-E32AB0EE498DQ54961174-2B31C26C-F544-4AEF-88E9-2F8D2F10D7D0Q54965803-2E46AC23-AF88-4C0A-9813-84C8D178D1E6Q55296470-EF1A271F-E66D-49A7-8183-36410D2E46D1Q57314038-A630BCAD-2F87-4682-8711-A5AA0725D027
P2860
Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Relevance of P-glycoprotein in ...... an, rivaroxaban, and apixaban.
@en
type
label
Relevance of P-glycoprotein in ...... an, rivaroxaban, and apixaban.
@en
prefLabel
Relevance of P-glycoprotein in ...... an, rivaroxaban, and apixaban.
@en
P2860
P1433
P1476
Relevance of P-glycoprotein in ...... an, rivaroxaban, and apixaban.
@en
P2093
C Stöllberger
J Finsterer
P2860
P304
P356
10.1007/S00059-014-4188-9
P478
40 Suppl 2
P577
2015-01-25T00:00:00Z